Wan,Zuxing – Trademark Portfolio

Entity Type: 01

Wan,Zuxing holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BFHB, OHRUERO, and MUSIBEAUTY. The owner is based in Hunan Province.

Chitang formation, Nanchong village,

Xiantang Town, Hengnan County,

Hunan Province 421131 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BFHB
BFHB
Registered 2021
OHRUERO
OHRUERO
Registered 2021

Trademark Classifications

Wan,Zuxing's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Wan,Zuxing have?

Wan,Zuxing has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Wan,Zuxing file in?

Wan,Zuxing files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 9 (Computers & Electronics). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Wan,Zuxing's most well-known trademarks?

Wan,Zuxing's registered trademark portfolio includes well-known marks such as BFHB, OHRUERO, and MUSIBEAUTY. These are among 3 currently registered trademarks in the portfolio.

What is Wan,Zuxing's trademark registration success rate?

Wan,Zuxing has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.